Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Freeman

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Scientific Reports|July 2, 2016
In vivo assessment of behavioral recovery and circulatory exchange in the peritoneal parabiosis modelJoseph M Castellano, Mikael Palner, Shi-Bin Li, et al.
The Science of the Total Environment|August 9, 2019
A systems approach to assessing environmental and economic effects of food loss and waste interventions in the United StatesMary K Muth, Catherine Birney, Amanda Cuéllar, et al.
F1000Research|September 23, 2017
Revisiting inconsistency in large pharmacogenomic studiesZhaleh Safikhani, Petr Smirnov, Mark Freeman, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2020
Development of autotaxin inhibitors: A series of tetrazole cinnamidesChristopher G Thomson, Darren Le Grand, Mark Dowling, et al.
Bioinformatics (Oxford, England)|December 15, 2015
PharmacoGx: an R package for analysis of large pharmacogenomic datasetsPetr Smirnov, Zhaleh Safikhani, Nehme El-Hachem, et al.
Cancers|August 29, 2024
Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding ComplicationsCha Len Lee, Mark Freeman, Kelly W Burak, et al.
Science (New York, N.Y.)|May 25, 2023
US benefit-cost analysis requires revisionPeter H Howard, Max Sarinsky, Michael Bauer, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2018
Development of autotaxin inhibitors: A series of zinc binding triazolesChristopher G Thomson, Darren Le Grand, Mark Dowling, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Scientific Reports|July 2, 2016
In vivo assessment of behavioral recovery and circulatory exchange in the peritoneal parabiosis modelJoseph M Castellano, Mikael Palner, Shi-Bin Li, et al.
The Science of the Total Environment|August 9, 2019
A systems approach to assessing environmental and economic effects of food loss and waste interventions in the United StatesMary K Muth, Catherine Birney, Amanda Cuéllar, et al.
F1000Research|September 23, 2017
Revisiting inconsistency in large pharmacogenomic studiesZhaleh Safikhani, Petr Smirnov, Mark Freeman, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2020
Development of autotaxin inhibitors: A series of tetrazole cinnamidesChristopher G Thomson, Darren Le Grand, Mark Dowling, et al.
Bioinformatics (Oxford, England)|December 15, 2015
PharmacoGx: an R package for analysis of large pharmacogenomic datasetsPetr Smirnov, Zhaleh Safikhani, Nehme El-Hachem, et al.
Cancers|August 29, 2024
Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding ComplicationsCha Len Lee, Mark Freeman, Kelly W Burak, et al.
Science (New York, N.Y.)|May 25, 2023
US benefit-cost analysis requires revisionPeter H Howard, Max Sarinsky, Michael Bauer, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2018
Development of autotaxin inhibitors: A series of zinc binding triazolesChristopher G Thomson, Darren Le Grand, Mark Dowling, et al.
Pageof 6